Content Engine

Clinical Insights & Research

Weekly articles, clinical deep-dives, and evidence-based guides building R3's authority across search engines and AI platforms.

Ex vivo data shows Redensyl® achieves +214% hair growth — nearly double Minoxidil's +118%.

Source: Givaudan Induchem, 84-Day Clinical Study #26-Male

DNA microarray reveals +85% Noggin and +56% FGF-7 expression in just 14 days.

Source: Mibelle Biochemistry, 14-Day DNA Microarray #10-Volunteer

6-month double-blind data: +18% density, A/T ratio 3.5→5.9, up to 38,000 new hairs.

Source: Provital Group, 6-Month Double-Blind Study #61-Volunteer

How Baicapil™'s baicalin activates telomerase reverse transcriptase to delay follicle aging.

Source: Provital Group, In-Vitro TERT Activation Assay

How GCC-specific factors affect treatment strategy and why multi-mechanism matters more.

Source: Regional Dermatological Literature Review, GCC Environmental Factors

DHQG achieves >3x β-catenin upregulation — the differentiation switch that initiates new hair.

Source: Givaudan Induchem, ORSc Stem Cell Proliferation Assay